Rituximab for Autoimmune Retinopathy

Clinical trial NCT01086631 · COMPLETED

Trial details

NCT number: NCT01086631
Sponsor: National Eye Institute (NEI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Disease

Start date: 2010-01-22
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.